Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model

Indoleamine 2,3-dioxygenase (IDO) is involved in tumor immune escape and resistance to chemotherapy, and is clinically correlated with tumor progression. IDO inhibitors show marginal efficacy as single agents; therefore, combinations of these inhibitors with other therapies hold promise for cancer t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Immunopathol Pharmacol
Main Authors: Meng, Xiangjing, Du, Guangying, Ye, Liang, Sun, Shanyue, Liu, Qiaofeng, Wang, Hongbo, Wang, Wenyan, Wu, Zimei, Tian, Jingwei
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815254/
https://ncbi.nlm.nih.gov/pubmed/28604143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0394632017714696
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados